Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01449370 |
| Title | Dose Escalation Study of MLN1117 in Subjects With Advanced Cancer |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Millennium Pharmaceuticals, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | GBR | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Boston | Massachusetts | United States | Details | |||
| Detroit | Michigan | United States | Details | |||
| Dallas | Texas | United States | Details | |||
| Barcelona | Spain | Details | ||||
| Sutton | United Kingdom | Details |